- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Phytopreparation of general tonic action. It has a tonic, tonic and psychogogic effect. Increases vascular tone, positively affects the metabolism of amino acids, lipids, histamine. Improves the functional activity of the cardiovascular and nervous systems. Increases mental and physical performance, as well as the adaptive ability of the organism. Reduces lethargy, drowsiness, feeling tired.
Data on the pharmacokinetics of the drug Doppelgerts® Ginseng is not provided.
- Asthenic syndrome;
- neurasthenic syndrome;
- prolonged mental and physical exhaustion;
- to increase the body's resistance to stressful situations and adverse environmental influences;
- in the period of recovery after illness;
- to improve performance and concentration.
1 capsule contains:
Active substances: ginseng root powder present 180 mg.
Excipients: microcrystalline cellulose - 55 mg, high-chain glyceride - 10 mg. The mass of the contents of the capsule is 245 mg.
The composition of the capsule shell: gelatin - 47.55-58.12 mg, iron yellow oxide (E172) - 0.15-0.18 mg, iron red oxide (E172) - 0.01-0.02 mg, titanium dioxide (E171) - 0 , 91-1.2 mg, sodium lauryl sulfate - 0.07-0.09 mg, purified water - 7.94-9.7 mg. Capsule shell weight is 56.6-69.3 mg. The nominal mass of the capsule is 301.6-314.3 mg.
Ginseng is marketed under different brands and generic names, and comes in different dosage forms:
|Brand name||Manufacturer||Country||Dosage form|
|Doppelgerz Ginseng||Khaisser Pharma||Germany||capsules|
|Doppelgerz Ginseng Active||Khaisser Pharma||Germany||vials|
|Ginseng tincture||Camelia NPP||Russia||tincture|
No customer reviews for the moment.
Dosage and Administration
Capsules accept without chewing, washing down with a small amount of water.
From the digestive system: abdominal pain, nausea, vomiting, diarrhea.
Since the cardiovascular system: increased blood pressure, tachycardia.
From the side of the central nervous system: headache, nervousness, insomnia.
Other: allergic reactions, nosebleeds, hypoglycemia.
- Hypersensitivity to the drug;
- arterial hypertension;
- increased nervous irritability;
- increased bleeding;
- fever in acute infectious diseases;
- breastfeeding period;
- children's age up to 12 years.
With the simultaneous use of Doppelgerts® Ginseng enhances the action of psychostimulants and analeptics (including caffeine, camphor).
With the simultaneous use of Doppelgerts® Ginseng shows antagonism when interacting with drugs that depress the central nervous system (antiepileptic drugs, antipsychotics, tranquilizers, sedatives).
With the simultaneous use of Doppelgerts® Ginseng enhances the effect of hypoglycemic drugs.
With the simultaneous use of Doppelgerts® Ginseng enhances the effect of warfarin.
With the simultaneous use of Doppelherz ® Ginseng increases the risk of developing resistance to "loop" diuretics.
Pregnancy and Lactation
The drug is contraindicated for use during pregnancy and during breastfeeding.
The therapeutic effect is observed after 2 weeks of taking the drug. There is a pronounced seasonality of action: the application in the autumn and winter is most effective.
Do not use the drug in the afternoon.
It should be borne in mind that if weakness, fatigue and loss of attention are observed for a longer time and are caused by unclear reasons, additional medical examination should be conducted.
Impact on the ability to drive vehicles and other mechanisms that require high concentration of attention
The drug does not affect the performance of potentially hazardous activities that require special attention and quick reactions (driving and other vehicles, working with moving machinery, the work of the dispatcher and operator, etc.).
Symptoms: If the recommended doses are exceeded, side effects may increase.
Treatment: conduct symptomatic therapy.
- American ginseng and breast cancer therapeutic agents synergistically inhibit MCF-7 breast cancer cell growth
- Effect of ginseng pretreatment on cerebral glucose metabolism in ischaemic rats using animal positron emission tomography (PET) and [18F]-FDG
- Evaluation of radiomodifying effects of root extract of Panax ginseng
- Non-ginsenoside nicotinic activity in ginseng species
- Tyrosinase inhibitory p-Coumaric acid from Ginseng leaves
- Transcriptional activation of Cu/Zn superoxide dismutase and catalase genes by panaxadiol ginsenosides extracted from Panax ginseng
- Adrenocorticosterone alterations in male, albino mice treated with Trichopus zeylanicus, Withania somnifera and Panax ginseng preparations
- Synthesis of Ginseng Diyne Analogues and Their Antiproliferative Activity against L1210 Cells
- Proteome of Oriental ginseng Panax ginseng C. A. Meyer and the potential to use it as an identification tool
- Medical Toxicology of Natural Substances || Ginseng
- Protective effects of ginseng components in a rodent model of neurodegeneration
- Ginseng-Anpflanzung in Japan
- Acetylpanaxydol und Panaxydolchlorhydrin, zwei neue, gegen L1210-Zellen cytotoxische Polyine aus Koreanischem Ginseng
- Pharmacokinetics of a ginseng saponin metabolite compound K in rats
- Korean red ginseng extract does not cause embryo-fetal death or abnormalities in mice
- Sterilization of ginseng using a high pressure CO2 at moderate temperatures
- Determination of panaxadiol and panaxatriol in ginseng and its preparations by capillary supercritical fluid chromatography (SFC)
- Improved high performance liquid chromatographic determination of ginsenosides in Panax ginseng-based pharmaceuticals using a diol column
- Purification and characterization of a superoxide dismutase from Panax ginseng
- Pesticide multiresidue analysis in Panax ginseng (C. A. Meyer) by solid-phase extraction and gas chromatography with electron capture and nitrogen-phosphorus detection
- Determination of volatile organic compounds generated from fresh, white and red Panax ginseng (C. A. Meyer) using a direct sample injection technique